Given the limited treatment options currently available for alcohol abuse, effective therapeutic targets for medication development are of critical importance. Since neuroinflammation is implicated in the etiology of alcoholism and other brain diseases, neuroimmune pathways offer unexplored targets for treating alcohol abuse.
